Study on the expression of coagulation factor mediated by recombinant AAV serotype 8

Progress in Biochemistry and Biophysics

Volumn 34, Issue 1, 2007, Pages 80-86

  Cao, Zuo Wu ^a   Li, Guan Gui ^a   Liang, Yu Qiang ^a   He, Dong Mei ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

AAV; Coagulation factor; Intraperitoneal injection

Indexed keywords

MUS;

EID: 34248581614     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gao G P, Alvira M R, Wang L, et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA, 2002, 99 (18): 11854-11859
2. Wang Z, Zhu T, Qiao C P, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nature Biotechnology, 2005, 23 (3): 321-328
3. Snyder R O, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nature Medicine, 1999, 5 (1): 64-70
4. Zolotukhin S, Byrne B J, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy, 1999, 6: 973-985
5. Grieger J C, Samulski R J. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virology, 2005, 79 (15): 9933-9944
6. Lin H F, Maeda N, Smithies O, et al. A coagulation factor IX -deficient mouse model for human hemophilia B. Blood, 1997, 90 (10): 3962-3966
7. Walter J, You Q, Hagstrom J N, et al. Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Proc Natl Acad Sci USA, 1996, 93 (7): 3056-3061
8. Nakai H, Herzog R W, Hagstrom J N, et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood, 1998, 91 (12): 4600-4607
9. Hagstrom J N, Couto L B, Scallan C, et al. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood, 2000, 95 (8): 2536-2542
10. Chao H, Liu Y, Rabinowitz J, et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Molecular Therapy, 2000, 2 (6): 619-623
11. Broekman M L D, Comer A C L A, Hymanb A B T, et al. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience, 2006, 138 (2) 501-510
12. Klein R L, Dayton R D, Leidenheimer N J, et al. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Molecular Therapy, 2006, 13 (3): 517-527
13. Barbon C M, Ziegler R J, Li C, et al. AAV8-Mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of niemann-pick disease. Molecular Therapy, 2005, 12 (3): 431-440
14. Davidoff A M, Gray J T, Ng C Y C, et al. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Molecular Therapy, 2005, 11 (6): 875-888
15. Sarkar R, Tetreault R, Gao GP, et al. Total correction of hemophilia a mice with canine FV III using anAAV 8 serotype. Blood, 2004, 103 (4): 1253-1260
16. Ding Z, Georgiev P, Thony B. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer. Gene Therapy, 2006, 13 (7): 587-593